Knowles signs deal to manufacture Elucent Medical surgical guidance device for EnVisio system
Reuters2026/08/12 04:04- Knowles signed an agreement to manufacture Elucent Medical’s smart surgical guidance device for the EnVisio In-Body Spatial Intelligence system.
- Production will run at an ISO 13485-certified, FDA-registered facility in Penang, Malaysia.
- Work includes design-for-manufacturability support, micro molding, and vertically integrated assembly to scale production and shorten time to market.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Will a 10-year US Treasury yield rising to 5.5% "attack" US stocks? Societe Generale warns: this could be the valuation tipping point.
Bokobza, Global Head of Asset Allocation at Société Générale, pointed out that if the 10-year U.S. Treasury yield reaches 5.5%, corporate profit growth will not be sufficient to offset the impact of rising rates on valuations, and the stock market will face substantial pressure. However, he believes that the upcoming rate hikes by the Federal Reserve and the European Central Bank will be relatively limited and will not disrupt the current economic cycle.
Himalaya Shipping option holder exercises 25,000 shares at USD 5.83 strike price
IBI-Lion SOCIMI sets EUR 0.031-per-share capital return distribution